PMPRB Summary of VCUs & Orders - 2004

Click on medicine to view details of VCU

DATE OF APPROVAL MEDICINE PATENTEE %Above Guidelines PRICE REDUCTION1 EXCESS REVENUES2 PAYMENTS PATENT STATUS
VCUs
Nov. 16, 2004 Busulfex ESP Pharma Over 7 Yes - to $359.8928/ampoule $144,215.55 $144,215.55 Expiration 08/2014
July 15, 2004 Starnoc Servier Canada Inc. Yes - from $1.00 to $0.4964 and $1.23 to $0.7474 $739,739.99 –See VCU $739,739.99 Expired 06/2007
July 9, 2004 Prolastin Bayer Inc. $288 MNE + CPI - See VCU for details Expiration 03/2009
June 25, 2004 Fasturtec11 Sanofi-Synthelabo Canada Inc. Yes - $295/vial to $125/vial - See VCU for details Expiration 07/2010; 05/2015
May 6, 2004 One-Alpha LEO Pharma Inc. See VCU for details $23,049.10 $23,049.10 Expired 05/2004
ORDER

1.There are no price reductions in cases where the PMPRB's jurisdiction ceased with the expiry or the dedication (prior to 1995) of the patent.

2. In all cases, all excess revenues were offset through further price reduction and/or payment.

11. Notice of Hearing issued on May 20, 2004.

Date modified: